Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Clinical trial NCT04926181 · TERMINATED

Trial details

NCT number: NCT04926181
Sponsor: Rahul Aggarwal
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Neuroendocrine Carcinoma Prostate Cancer Small Cell Carcinoma

Start date: 2022-03-16
Primary completion: 2024-03-31
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.